Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 538 across all filing types
Latest filing 2023-12-20 Board/Management Inform…
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Board/Management Information 2023
Board/Management Information Classification · 1% confidence The document is an official announcement (ANNOUNCEMENT NO. 248) detailing a change in senior management: COO and deputy chairman Martin Glensbjerg is stepping down from his executive role to become a Senior Advisor, and new appointments for COO and Chief R&D Officer are made. This content directly relates to changes in the company's senior management team. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and is an announcement, not a comprehensive report.
2023-12-20 English
Director's Dealing 2023
Director's Dealing Classification · 1% confidence The document title is "Indberetning af ledende medarbejderes transaktioner" (Reporting of transactions by leading employees/management). It explicitly mentions that the company received a report regarding transactions in ChemoMetec A/S shares performed by persons discharging managerial responsibilities (PDMRs), referencing Article 19 of Regulation (EU) No 596/2014. This directly corresponds to the definition of Director's Dealing (insider trades by executives). The document itself is a short announcement referring to an attached PDF for the detailed transaction report. However, the core subject matter is the insider transaction report, which maps precisely to the 'Director's Dealing' category. The code for Director's Dealing is DIRS.
2023-09-14 Danish
Director's Dealing 2023
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Notification of managers’ transactions' and references Article 19 of EU Regulation no. 596/2014 concerning transactions by persons discharging managerial responsibilities (PDMRs). This directly corresponds to the definition of Director's Dealing (insider trades). Although it mentions an 'Attachment' containing the details, the primary purpose and content of this announcement is to report the transaction, making 'DIRS' the most accurate classification over a general 'RPA' or 'RNS'. The document length is short, but the core subject matter is specific enough to override the general RPA rule.
2023-09-14 English
Indberetning af ledende medarbejderes transaktioner
Director's Dealing Classification · 1% confidence The document follows the standard template for 'notification and public disclosure of transactions by persons discharging managerial responsibilities' (PDMR). It explicitly lists the CEO (Rasmus Kofoed) as the person discharging managerial responsibilities and details a purchase of shares in ChemoMetec A/S. This is a classic insider trading disclosure, which corresponds to the 'Director's Dealing' category.
2023-09-14 English
Indberetning af ledende medarbejderes transaktioner
Director's Dealing Classification · 1% confidence The document is a standard regulatory form used in the EU (specifically Denmark, indicated by 'Finanstilsynet') for reporting transactions by persons discharging managerial responsibilities (PDMRs). It identifies the individual (Rasmus Kofoed, CEO), the issuer (ChemoMetec), the nature of the transaction (purchase of shares), and the date. This falls under the category of Director's Dealing.
2023-09-14 Danish
Report Publication Announcement 2022
Report Publication Announcement Classification · 1% confidence The document is a short announcement (Meddelelse nr. 243) from ChemoMetec A/S regarding the release of their Annual Report 2022/23. It provides a summary of financial highlights and explicitly states that the full report is 'attached' (Vedhæftet denne meddelelse) and available for download via a link. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the full annual report itself, it is classified as a Report Publication Announcement. FY 2022
2023-09-13 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.